Seth Hardy, MD, MBA

    Calculated based on number of publications stored in Pure and citations from Scopus
    1996 …2024

    Research activity per year

    If you made any changes in Pure these will be visible here soon.

    Personal profile

    Research interests

    Dr. Seth Hardy's research interests are at the intersection of hematology/oncology, imaging, patient-centered care and value creation. As a leukemia survivor himself, currently enrolled in a Phase II trial at the National Institutes of Health, he has a patient's perspective on the delivery of hematology/oncology care, clinical trials and potential shortcomings in today's medical environment.

    He is currently developing a pilot clinical trial in patients on checkpoint inhibitors to develop imaging biomarkers that may provide efficacy feedback inside the typical CT/MR iRECIST 16-week cycle. He also co-leads an ad hoc sono-oncology workgroup across campuses at Penn State.

    Dr. Hardy also publishes on economic and strategic topics within imaging and medicine.

    Expertise related to UN Sustainable Development Goals

    In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

    • SDG 3 - Good Health and Well-being

    External positions

    Oncology Scientific Advisory Board member, New Century Health

    2019 → …


    Dive into the research topics where Seth Hardy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or